MYGN - MYRIAD GENETICS INC

QQQ $ 451.64 $ -0.92 (-0.2 %)

DIA $ 399.14 $ -0.07 (-0.02 %)

SPY $ 528.49 $ -1.29 (-0.24 %)

TLT $ 92.06 $ -0.04 (-0.04 %)

GLD $ 220.06 $ -0.86 (-0.39 %)

Previous Close

$ 24.61

Open

$ 24.46

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 23.80 - $ 24.88

52 Week Range

$ 13.82 - $ 25.95

Volume

899,169

Average Volume

Market Cap

2.21B

Beta (5Y Monthly)

$ 1.38

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-08-2024	03-31-2024	10-Q
2	02-28-2024	12-31-2023	10-K
3	11-07-2023	09-30-2023	10-Q
4	08-04-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	03-01-2023	12-31-2022	10-K
7	11-02-2022	09-30-2022	10-Q
8	08-05-2022	06-30-2022	10-Q
9	05-06-2022	03-31-2022	10-Q
10	02-25-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-04-2021	06-30-2021	10-Q
13	05-05-2021	03-31-2021	10-Q
14	11-09-2020	09-30-2020	10-Q
15	08-13-2020	06-30-2020	10-K
16	05-06-2020	03-31-2020	10-Q
17	02-07-2020	12-31-2019	10-Q
18	11-06-2019	09-30-2019	10-Q
19	08-13-2019	06-30-2019	10-K
20	05-08-2019	03-31-2019	10-Q
21	02-06-2019	12-31-2018	10-Q
22	11-07-2018	09-30-2018	10-Q
23	08-24-2018	06-30-2018	10-K
24	05-09-2018	03-31-2018	10-Q
25	02-07-2018	12-31-2017	10-Q
26	11-08-2017	09-30-2017	10-Q
27	08-09-2017	06-30-2017	10-K
28	05-03-2017	03-31-2017	10-Q
29	02-08-2017	12-31-2016	10-Q
30	11-02-2016	09-30-2016	10-Q
31	08-10-2016	06-30-2016	10-K
32	05-04-2016	03-31-2016	10-Q
33	02-03-2016	12-31-2015	10-Q
34	11-04-2015	09-30-2015	10-Q
35	08-12-2015	06-30-2015	10-K
36	05-06-2015	03-31-2015	10-Q
37	02-04-2015	12-31-2014	10-Q
38	11-05-2014	09-30-2014	10-Q
39	08-13-2014	06-30-2014	10-K
40	05-07-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Myriad Genetics Study Published In JCO Pre...
05/16/2024 20:30:28

Myriad's Prolaris Test is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiat...

Piper Sandler Maintains Neutral on Myriad ...
05/13/2024 12:55:45

Piper Sandler analyst John Peterson maintains Myriad Genetics (NASDAQ:MYGN) with a Neutral and raises the price target from ...

Leerink Partners Upgrades Myriad Genetics ...
05/08/2024 17:54:35

Leerink Partners analyst Puneet Souda upgrades Myriad Genetics (NASDAQ:MYGN) from Market Perform to Outperform and raises th...

why-upstart-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Upstart Shares Are Trading Lower By Ar...
05/08/2024 17:38:56

louisiana-pacific-posts-upbeat-results-joins-cricut-elanco-animal-american-public-education-and-other-big-stocks-moving-higher-on-wednesday

Louisiana-Pacific Posts Upbeat Results, Jo...
05/08/2024 15:11:22

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
05/08/2024 12:06:34

Myriad Genetics Sees FY24 Adj. EPS $0.00-$...
05/07/2024 21:41:41

Myriad Genetics Q1 2024 Adj EPS $(0.01) Be...
05/07/2024 21:22:20

Myriad Genetics (NASDAQ:MYGN) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.1...

Myriad Genetics Announces Reorganization O...
05/07/2024 13:06:57

Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced the reorganization of...

New Myriad Genetics Published Study Demons...
04/16/2024 13:18:59

Myriad Genetics Research Shows Reduction I...
04/09/2024 12:05:05

Reported Earlier, Myriad Genetics Granted ...
03/22/2024 07:14:37

Myriad Genetics Says US Patent And Tradema...
03/20/2024 20:08:13

U.S. Patent No. 11,932,907, titled Fetal Sex Determination Using Capillary Blood From Upper Arm, provides protection for Myriad...

Myriad Genetics Sees 2024 Adj. EPS $0.00-$...
02/27/2024 22:08:46

Myriad Genetics: Q4 Earnings Insights
02/27/2024 21:50:09

Myriad Genetics Q4 2023 Adj EPS $0.04 Beat...
02/27/2024 21:47:53

Myriad Genetics (NASDAQ:MYGN) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.01...

Myriad Genetics And National Cancer Center...
02/27/2024 14:16:51

Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced a research collaborati...

Earnings Scheduled For February 27, 2024
02/27/2024 10:01:31

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

Myriad Genetics Earnings Preview
02/26/2024 16:01:44

Goldman Sachs Maintains Buy on Myriad Gene...
01/30/2024 13:59:39

Goldman Sachs analyst Matthew Sykes maintains Myriad Genetics (NASDAQ:MYGN) with a Buy and raises the price target from $28 ...